About ImmunoStar
ImmunoStar is a company based in Hudson (United States) founded in 1975. It operates as a B2B. ImmunoStar offers products and services including Antibody Catalog, Peptide Control Catalog, Alzheimer’s Antibodies, and 5-HT Antibodies. ImmunoStar operates in a competitive market with competitors including GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
- Headquarter Hudson, United States
- SectorsHealthcare
- Website immunostar.com
- Social X Facebook
- Legal Name Immunostar, Inc.
Products & Services of ImmunoStar
ImmunoStar offers a comprehensive portfolio of products and services, including Antibody Catalog, Peptide Control Catalog, Alzheimer’s Antibodies, and 5-HT Antibodies.
Catalog of primary antibodies for neuroscience studies
Collection of peptide controls for experimental validation
Antibodies targeted for Alzheimer’s disease research applications
Antibodies for serotonin research in neuroscience
Competitors of ImmunoStar
ImmunoStar operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| sinobiological.com | 2007 | Beijing, China | $29.41M | – | Reagents and kits are provided for clinical research applications. | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | – | Monoclonal antibody technology and products are developed by Epitomics. | |
| ybiologics.com | 2007 | Daejeon, South Korea | $42.1M | – | Developer of antibodies for the treatment of multiple diseases | |
| mabtech.com | 1986 | Nacka, Sweden | – | – | Antibodies and immunoassay kits are developed for research applications. | |
| opmbiosciences.com | 2013 | Pudong, China | $14.42M | – | Antibody and vaccine culture media products are developed. | |
| itb-med.com | 2016 | Stockholm, Sweden | $87M | – | Monoclonal antibodies are developed to prevent transplant rejections. | |
| abrevbio.com | 2018 | Nanjing, China | $90M | – | Antibody-drug development platforms are provided for life sciences research. | |
| vectorlabs.com | 1976 | Burlingame, United States | – | – | Labeling and detection reagents immunohistochemistry studies and other life science research applications | |
| allelebiotech.com | 1999 | San Diego, United States | $18M | – | Nano-antibodies, iPSCs, fluorescent proteins, and RNAi are developed. |
Detailed competitors of ImmunoStar
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ImmunoStar
Websites that share an audience with ImmunoStar (immunostar.com).
Websites whose visitors overlap most with ImmunoStar. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| sysy.com | 93% | 55.8K | #662,877 | View details | |
| antibodiesinc.com | 91% | 21K | #1,321,745 | View details | |
| mitosciences.com | 88% | – | – | View details | |
| citeab.com | 84% | 601.8K | #63,627 | View details | |
| kpl.com | 82% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for ImmunoStar
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to ImmunoStar
10 companies that operate in the same segment as ImmunoStar (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ImmunoStar
ImmunoStar was founded in 1975.
ImmunoStar is headquartered in Hudson, United States.
Immunostar produces primary polyclonal and monoclonal antibodies for neuroscience research, focusing on high-titer products sold at fair prices. The company operates as a manufacturer and distributor, serving researchers through direct sales and international orders. Based in Hudson, Wisconsin, it emphasizes quality validated by thousands of citations in biomedical literature. Products include catalogs for antibodies and controls, targeting areas like Alzheimers and serotonin research.
ImmunoStar's top competitors include Sino Biological, GenScript and Y-Biologics.
ImmunoStar offers Antibody Catalog, Peptide Control Catalog, Alzheimer’s Antibodies, and 5-HT Antibodies.
ImmunoStar operates through Immunostar, Inc..